Mahesh B Chandrasekharan
Has grant
Investigator
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Mahesh B Chandrasekharan is an Assistant Professor at the University of Utah School of Medicine, United States. His research focuses on the mechanisms of gene regulation, particularly in the context of histone modifications, DNA repair, and cellular reprogramming. He has published recent articles exploring topics such as ubiquitination dynamics and the roles of transcription factors in lineage specification.
Recent Grants
Grant: Close
A versatile pan-spike-in internal reference genome methodology for quantitative ChIP-seq normalization
Open Date: 2021-01-01
Close Date: 2022-12-31
Grant: Close
Structure, function and regulation of the H2B ubiquitin-conjugating complex
Open Date: 2018-05-01
Close Date: 2023-04-30
Grant: Close
Genome-wide occupancy and orientation mapping of nucleosomes asymmetrically modified at histone H3 lysine-4-a novel mark of active transcription
Open Date: 2017-04-19
Close Date: 2019-03-31
Articles (13)
Year:
2026
Year:
2026
Year:
2025
Year:
2024
The transition between pluripotent and tissue-specific states is a key aspect of development. Understanding the pathways driving these transitions will facilitate the engineering of properly differentiated cells for experimental and therapeutic uses. Here, we showed that during mesoderm differentiation, the transcription factor Oct1 activated developmental lineage–appropriate genes that were silent in pluripotent cells. Using mouse embryonic stem cells (ESCs) with an inducible knockout of Oct1, we showed that Oct1 deficiency resulted in poor induction of mesoderm-specific genes, leading to impaired mesodermal and terminal muscle differentiation. Oct1-deficient cells exhibited poor temporal coordination of the induction of lineage-specific genes and showed inappropriate developmental lineage branching, resulting in poorly differentiated cell states retaining epithelial characteristics. In ESCs, Oct1 localized with the pluripotency factor Oct4 at mesoderm-associated genes and remained bound to those loci during differentiation after the dissociation of Oct4. Binding events for Oct1 overlapped with those for the histone lysine demethylase Utx, and an interaction between Oct1 and Utx suggested that these two proteins cooperate to activate gene expression. The specificity of the ubiquitous Oct1 for the induction of mesodermal genes could be partially explained by the frequent coexistence of Smad and Oct binding sites at mesoderm-specific genes and the cooperative stimulation of mesodermal gene transcription by Oct1 and Smad3. Together, these results identify Oct1 as a key mediator of mesoderm lineage–specific gene induction.
Year:
2023
The conserved complex of the Rad6 E2 ubiquitin-conjugating enzyme and the Bre1 E3 ubiquitin ligase catalyzes histone H2B monoubiquitination (H2Bub1), which regulates chromatin dynamics during transcription and other nuclear processes. Here, we report a crystal structure of Rad6 and the non-RING domain N-terminal region of Bre1, which shows an asymmetric homodimer of Bre1 contacting a conserved loop on the Rad6 ‘backside’. This contact is distant from the Rad6 catalytic site and is the location of mutations that impair telomeric silencing in yeast. Mutational analyses validated the importance of this contact for the Rad6–Bre1 interaction, chromatin-binding dynamics, H2Bub1 formation and gene expression. Moreover, the non-RING N-terminal region of Bre1 is sufficient to confer nucleosome binding ability to Rad6 in vitro. Interestingly, Rad6 P43L protein, an interaction interface mutant and equivalent to a cancer mutation in the human homolog, bound Bre1 5-fold more tightly than native Rad6 in vitro, but showed reduced chromatin association of Bre1 and reduced levels of H2Bub1 in vivo. These surprising observations imply conformational transitions of the Rad6–Bre1 complex during its chromatin-associated functional cycle, and reveal the differential effects of specific disease-relevant mutations on the chromatin-bound and unbound states. Overall, our study provides structural insights into Rad6–Bre1 interaction through a novel interface that is important for their biochemical and biological responses.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Collaborators (9)
Lauren Woodward
Assistant Professor
Taylor University
Hiroshi Handa
Tokyo Medical and Dental University
Krzysztof Mrózek
The Ohio State University Comprehensive Cancer Center
Eric Huang
University of Utah
Dimitrios Papaioannou
Assistant Professor
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
Dean Tantin
Associate Professor
University of Utah School of Medicine
Amog Prathap Urs
Research Scientist
Huntsman Cancer Institute
Rémi Buisson
Associate Professor
University of California, Irvine
Deedra Nicolet
Ohio State University
Make your next move.
Prepare your application
Review drafts before you send them.